DCGI
-
Kolkata hospital likely to begin trial of Russia’s COVID-19 vaccine
The health department has awaiting DCGI approval and necessary surveys have been carried out by a site management organisation Phase-II…
Read More » -
BDR Receives DCGI Approval for the Launch of Favipiravir to Treat COVID-19 in India
Mumbai : BDR Pharmaceuticals today announced the launch of Favipiravir for the treatment of COVID-19 patients in India. BDR Pharma…
Read More »